SCHEMBL9059449

SCHEMBL9059449

CCCCNC(=O)NSc1c(C)cccc1N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
GAA P10253 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.41
AKR1C3 P42330 1/20 0.40
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059356 0.83 AKR1C3 (0.46) SMN1; SMN2L3MBTL1KDM4EAKR1C3ALDH1A1
SCHEMBL9059338 0.75 ALDH1A1 (0.42) SMN1; SMN2GAAL3MBTL1AKR1C3ALDH1A1
SCHEMBL9059454 0.73 ALDH1A1 (0.49) SMN1; SMN2GAAKDM4EALDH1A1MEN1
SCHEMBL9059530 0.71 MAPT (0.50) SMN1; SMN2GAAL3MBTL1ALDH1A1TSHR
SCHEMBL9059917 0.71 SMN1; SMN2 (0.41) SMN1; SMN2GAAL3MBTL1HTTKDM4E
SCHEMBL9059919 0.71 SMN1; SMN2 (0.41) SMN1; SMN2GAAL3MBTL1HTTKDM4E
SCHEMBL9060925 0.70 ALDH1A1 (0.38) SMN1; SMN2L3MBTL1HTTKDM4EAKR1C3
SCHEMBL12989307 0.69 MAPT (0.64) SMN1; SMN2GAAHTTALDH1A1MEN1
SCHEMBL7507203 0.69 HTT (0.55) SMN1; SMN2GAAHTTALDH1A1
SCHEMBL9059323 0.68 SMN1; SMN2 (0.44) SMN1; SMN2GAAL3MBTL1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed